Bluebird Bio Stock Is in Free Fall
Two weeks ago, bluebird bio secured Food and Drug Administration approval for its gene therapy for sickle cell disease, a significant milestone for the roughly 100,000 people in…
Read more Bluebird Bio Stock Is in Free Fall